SEASONAL MALARIA CHEMOPREVENTION - MALARIA CONSORTIUM

Malaria Consortium implements a Seasonal Malaria Chemoprevention (SMC) program in Africa's Sahel region, administering monthly antimalarial medicines (SP and AQ) to children aged 3 to 59 months during peak transmission season. This initiative aims to maintain protective drug levels, reducing malaria cases by up to 75% in the target population. In 2024, the organization planned to reach over 22.5 million children.

The program utilizes a door-to-door distribution method with trained community distributors to ensure high coverage and adherence, employing data-driven insights and digital tools for monitoring and evaluation. SMC platforms also integrate other health services like vitamin A supplementation. Malaria Consortium advocates for sustained financing and policy development through its role in the SMC Alliance.

This assignment explored the activities undertaken by Malaria Consortium teams in Jigawa and Kano State, Nigeria.

Mahmoud, The officer in charge of Sharada PHC prepares SMC medicines for dispatch to community drug distributors CDD.

A community distributor for Malaria Consortium holds a SPAQ Medicine to be distributed in Sharada PHC, Kano State, Nigeria

Lead mother advices a caregiver on the need to follow with their appointment with SMC drugs in Ringim village , Jigawa state, Nigeria

A child shows off her SMC child record card after a visit by the community drug distributors in Fanisau Mahauta, Kano state, Nigeria

A community drug Distributor records data from a SMC distrution on a mobile phone

A community drug distributor marks the homes of the families they have visited in Ungogo, Kano State, Nigeria

health workers at Sharada PHC, Kano State

A Health worker takes blood sample from a patient to conduct a malaria test at

A lab scientist conducts a malaria test at a lab in Sharada PHC, Kano State, Nigeria

Google Sites

Report abuse